Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
71,858,757
-
Total 13F shares
-
12,671,847
-
Share change
-
+57,949
-
Total reported value
-
$66,523,675
-
Price per share
-
$5.25
-
Number of holders
-
33
-
Value change
-
+$330,944
-
Number of buys
-
14
-
Number of sells
-
18
Institutional Holders of SINOVAC BIOTECH LTD. - Common Shares (SVA) as of Q2 2015
As of 30 Jun 2015,
SINOVAC BIOTECH LTD. - Common Shares (SVA) was held by
33 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,671,847 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, ORBIMED ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, Pine River Capital Management L.P., FIL Ltd, BlackRock Fund Advisors, FIRST MANHATTAN CO, Zurcher Kantonalbank (Zurich Cantonalbank), DEUTSCHE BANK AG\, and Eqis Capital Management, Inc..
This page lists
33
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.